ENvue Medical removes Series H Preferred Floor Price in exchange for $2.5M investment

ENvue Medical, Inc.

• Entered Amendment Agreement with Required Holders to file Certificate of Amendment removing Floor Price from Series H Convertible Preferred Stock.
• In consideration, holders exercised $2,500,000 of Additional Investment Right from July 2025 purchase agreement.
• Certificate of Amendment filed and effective January 30, 2026.
• The amendment modifies conversion rights of Series H Preferred by eliminating the Floor Price.
• Company receives $2.5M new capital from existing preferred holders.